ANI PHARMACEUTICALS, INC
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2020
Total Assets: $461.2M
Liabilities Breakdown FY2020
Total Liabilities: $265.5M
Asset Breakdown
Total Assets: $461.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $7.9M | 1.7% |
| Accounts Receivable | $95.8M | 20.8% |
| Inventory | $60.8M | 13.2% |
| Property, Plant & Equipment | $41.3M | 8.9% |
| Goodwill | $3.6M | 0.8% |
| Intangible Assets | $188.5M | 40.9% |
| Other Assets | $63.4M | 13.7% |
Liabilities Breakdown
Total Liabilities: $265.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $11.3M | 4.2% |
| Long-Term Debt | $172.4M | 65.0% |
| Other Liabilities | $81.8M | 30.8% |